Find similar content

Source channel @githubtrending · Post #14868 · Jun 26

#typescript#ai_gateway#gateway#generative_ai#hacktoberfest#langchain#llama_index#llmops#llms#openai#prompt_engineering#router The AI Gateway by Portkey lets you connect to over 1600 AI models quickly and securely through one simple API, making it easy to integrate any language, vision, or audio AI model in under two minutes. It ensures fast responses with less than 1ms latency, automatic retries, load balancing, and fallback options to keep your AI apps reliable and scalable. It also offers strong security with role-based access, guardrails, and compliance with standards like SOC2 and GDPR. You can save costs with smart caching and optimize usage without changing your code. This helps you build powerful, cost-effective, and secure AI applications faster and with less hassle. https://github.com/Portkey-AI/gateway

Hashtags

#typescript #ai_gateway #gateway #generative_ai #hacktoberfest #langchain #llama_index #llmops #llms #openai #prompt_engineering #router

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment